AstraZeneca PLC Backs Another Cambridge Biotech

Published: Jul 03, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AstraZeneca’s impact on the Cambridge medical technology cluster has gone up another notch with yet another deal involving a key player in the segment.

Having decided to bring its global HQ to the UK’s biomedical hotspot and following a string of deals with local companies, AZ has now backed Optibrium, a developer of software for drug discovery.

Help employers find you! Check out all the jobs and post your resume.

Back to news